Physician profile
Subroto Paul
NPI 1275648933
$22,543.14
in general payments reported to CMS, 2019-2025
9 companies · $5,606 in 2025
The $5,606 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,379 · 2020: $640 · 2021: $2,822 · 2022: $1,671 · 2023: $2,033 · 2024: $6,392 · 2025: $5,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,500 · Consulting Fee: $4,391 · Travel and Lodging: $2,331 · Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,500.00 |
| Consulting Fee | $4,391.00 |
| Travel and Lodging | $2,330.63 |
| Food and Beverage | $809.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,275.72 | 2019-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $6,288.38 | 2019-2025 | Imfinzi |
| Ethicon INC. | $1,500.30 | 2019-2022 | |
| Synapse Biomedical INC | $1,500.00 | 2023 | Neurx Diaphragm Pacing System |
| Covidien LP | $340.00 | 2020 | |
| Becton, Dickinson and Company | $230.00 | 2023 | |
| Davol INC. | $159.10 | 2024 | Arista Ah Flexitip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2021 | |
| Edwards Lifesciences Corporation | $124.64 | 2023 | Mitris Resilia Mitral Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subroto Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.